Home▸Multiple Sclerosis▸Acute Relapse Management with IV Steroids Simulator

🧠 Acute Relapse Management with IV Steroids Simulator

A simulation of a pulse therapy protocol using methylprednisolone (1000 mg/day for 3-5 days) to model the recovery of neurological deficits over time on the EDSS scale.

Multiple Sclerosis2DModerate60 FPS
ms-relapse-iv-steroid-simulator ↗ Open standalone

Acute Relapse Onset

A new lesion inflames. Function drops fast, EDSS spikes.

  • ~6.0: Relapse EDSS peak (acute deficit)
  • 1000 mg: Standard dose (IV methylprednisolone)
  • 3–5 d: Course length (daily pulse)
  • <72 h: Onset to peak (symptom escalation)

What triggers a relapse

Immune cells cross the blood-brain barrier, attack myelin locally.

Typical presentations

Optic neuritis, limb weakness, sensory loss, brainstem signs.

Why EDSS rises

New deficit adds disability points across functional systems.

Deficits worsening over 24–48h define a true relapse.

IV Methylprednisolone Pulse Begins

High-dose steroid infusion starts, day one of the course.

  • ~1 h: Infusion time (per daily dose)
  • Genomic: Mechanism class (anti-inflammatory)
  • 1 of 5: Course day (pulse start)
  • IV: Route (high-dose pulse)

Why IV, why high dose

Rapid, high tissue levels cross the leaky barrier fast.

Dosing pattern

1000mg once daily, typically for three to five days.

Molecular action

Glucocorticoid receptors dampen inflammatory gene expression.

Molecules diffuse straight to the inflamed lesion site.

Inflammation and Edema Recede

Swelling around the lesion falls as steroid levels build.

  • ↓60–80%: Inflammation cut (by course end)
  • Restored: Barrier effect (blood-brain barrier)
  • Reduced: Edema (at lesion site)
  • Suppressed: Immune infiltrate (locally)

Barrier repair

Tight junctions reseal, limiting further immune entry.

Edema resolution

Fluid clears, easing pressure on nearby axons.

Timing

Effect builds over the treatment days, not instantly.

More course-days completed, faster the swelling drops.

Neurological Recovery Unfolds

Conduction improves over days as inflammation subsides.

  • 1–3 wk: Recovery window (post-treatment)
  • Improving: Conduction (nerve signaling)
  • Declining: EDSS trend (toward baseline)
  • Partial repair: Myelin (remyelination)

Signal restoration

Less swelling lets axons conduct impulses again.

Recovery pace

Function returns gradually, days to a few weeks.

Steroids vs repair

Steroids speed recovery; true remyelination is slower.

Most improvement clusters in the first two weeks.

Relapse Resolution & Residual Deficit

EDSS improves a lot, but rarely all the way back.

  • ~2.8: Residual EDSS (vs 2.0 baseline)
  • Unchanged: Long-term course (disease trajectory)
  • Substantial: Recovery (not always complete)
  • Persists: Relapse risk (future episodes)

Incomplete return

A small residual deficit often remains after recovery.

Disability accrual

Repeated incomplete recoveries add up over time.

What steroids do not do

They treat the relapse, not the underlying disease course.

Disease-modifying therapy, not steroids, alters long-term risk.
⚙ Under the hood

A simulation of a pulse therapy protocol using methylprednisolone (1000 mg/day for 3-5 days) to model the recovery of neurological deficits over time on the EDSS scale.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)